All In MedTech

Device Trial Radar · NCT01186692

Melody® Transcatheter Pulmonary Valve Post-Approval Study

Implantation of the Medtronic Melody Transcatheter Pulmonary Valve (TPV) in Patients With Dysfunctional Right Ventricular Outflow Tract (RVOT) Conduits: A Post-Market Approval Study

Last checked: Nov 20, 2026Latest source record: May 1, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

131

Actual

Start

Jul 2010

Primary completion

Jan 2013

Study completion Oct 2017

Sponsor

Lead sponsor
Medtronic CardiovascularPublic (MDT)
Sponsor type
Industry
First posted
Aug 23, 2010

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to confirm the short-term hemodynamic effectiveness results achieved by real-world providers are equivalent to the historical control established in the IDE study.

Conditions

  • Dysfunctional Right Ventricular Outflow Tract (RVOT) Conduit

Interventions

  • Melody® Transcatheter Pulmonary ValveDevice

    Transcatheter Pulmonary Valve replacement Transcatheter valve implantation into a RVOT conduit in patients with complex congenital heart defects where the conduit has become dysfunctional and where the patient needs invasive intervention.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Acceptable TPV Hemodynamic Function at Six Months After Successful TPV ImplantationTime frame: 6 months

Locations

10 sites in 1 country. Site status is shown where the registry gives one.

  • Rady Children's Hospital

    San Diego, California

  • Advocate Hope Children's Hospital

    Oak Lawn, Illinois

  • CS Mott Children's Hospital, University of Michigan

    Ann Arbor, Michigan

7 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.